These are the regulatory T cell program clinical trials. All product manufacturing is done by the UCSF HICTF and GMP Laboratory.
Autoimmunity Clinical Trials
NCT02772679 - T1DM Immunotherapy Using Polyclonal Tregs + IL-2 (TILT)
NCT01210664 - T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs (Treg)
NCT03239470 - Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
NCT02428309 - Autologous Polyclonal Tregs for Lupus
Solid Organ Transplant Clinical Trials
NCT02474199 - Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction (ARTEMIS)
NCT02088931 - Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASKp)
NCT02711826 - Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK)
NCT02188719 - Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation (deLTa)
NCT02244801 - Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study ) (DART)